John Tilton
John Tilton
Associate Professor of Nutrition, Case Western Reserve University
Potvrđena adresa e-pošte na
HIV: cell binding and entry
CB Wilen, JC Tilton, RW Doms
Cold Spring Harbor perspectives in medicine 2 (8), a006866, 2012
Entry inhibitors in the treatment of HIV-1 infection
JC Tilton, RW Doms
Antiviral research 85 (1), 91-100, 2010
Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)
P Eissmann, L Beauchamp, J Wooters, JC Tilton, EO Long, C Watzl
Blood 105 (12), 4722-4729, 2005
Molecular mechanisms of HIV entry
CB Wilen, JC Tilton, RW Doms
Viral molecular machines, 223-242, 2012
Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered …
C Iyasere, JC Tilton, AJ Johnson, S Younes, B Yassine-Diab, RP Sekaly, ...
Journal of virology 77 (20), 10900-10909, 2003
COVID-19 and cardiovascular disease: from bench to bedside
MK Chung, DA Zidar, MR Bristow, SJ Cameron, T Chan, CV Harding III, ...
Circulation research 128 (8), 1214-1236, 2021
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7
NF Parrish, CB Wilen, LB Banks, SS Iyer, JM Pfaff, JF Salazar-Gonzalez, ...
PLoS pathogens 8 (5), e1002686, 2012
Entry inhibitors and their use in the treatment of HIV-1 infection
AA Haqqani, JC Tilton
Antiviral research 98 (2), 158-170, 2013
Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases
CB Wilen, J Wang, JC Tilton, JC Miller, KA Kim, EJ Rebar, SA Sherrill-Mix, ...
PLoS pathogens 7 (4), e1002020, 2011
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins
CB Wilen, NF Parrish, JM Pfaff, JM Decker, EA Henning, H Haim, ...
Journal of virology 85 (17), 8514-8527, 2011
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5
JC Tilton, CB Wilen, CA Didigu, R Sinha, JE Harrison, C Agrawal-Gamse, ...
Journal of virology 84 (20), 10863-10876, 2010
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
MK Chung, S Karnik, J Saef, C Bergmann, J Barnard, MM Lederman, ...
EBioMedicine 58, 102907, 2020
Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro
JC Tilton, MM Manion, MR Luskin, AJ Johnson, AA Patamawenu, ...
Journal of virology 82 (8), 3997-4006, 2008
Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons
JC Tilton, AJ Johnson, MR Luskin, MM Manion, J Yang, JW Adelsberger, ...
Journal of virology 80 (23), 11486-11497, 2006
CD4+ immune escape and subsequent T‐cell failure following chimpanzee immunization against hepatitis C virus
M Puig, K Mihalik, JC Tilton, O Williams, M Merchlinsky, M Connors, ...
Hepatology 44 (3), 736-745, 2006
Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+ T Cells …
JC Tilton, MR Luskin, AJ Johnson, M Manion, CW Hallahan, JA Metcalf, ...
Journal of virology 81 (6), 2713-2725, 2007
HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
JM Pfaff, CB Wilen, JE Harrison, JF Demarest, B Lee, RW Doms, JC Tilton
Journal of virology 84 (13), 6505-6514, 2010
Primary infection by a human immunodeficiency virus with atypical coreceptor tropism
C Jiang, NF Parrish, CB Wilen, H Li, Y Chen, JW Pavlicek, A Berg, X Lu, ...
Journal of virology 85 (20), 10669-10681, 2011
The Histone Deacetylase Inhibitor Vorinostat (SAHA) Increases the Susceptibility of Uninfected CD4+ T Cells to HIV by Increasing the Kinetics and Efficiency of …
MB Lucera, CA Tilton, H Mao, C Dobrowolski, CO Tabler, AA Haqqani, ...
Journal of virology 88 (18), 10803-10812, 2014
The NIH somatic cell genome editing program
K Saha, EJ Sontheimer, PJ Brooks, MR Dwinell, CA Gersbach, DR Liu, ...
Nature 592 (7853), 195-204, 2021
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20